FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to psychiatry, and can be used for prediction of compliance with therapy for further correction of patients with schizophrenia. Factors of risk of premorbid period are used, namely: belonging to make sex; presence of psychic disorders in more than one relative; excitable type of personality; "hypoprotection"-type upbringing in family; education: auxiliary school, incomplete secondary education or complete higher education; professional group: non-working and non-studying; marital status: divorced, widow(er); family composition: single; abuse with psychoactive substances; age group above 50. Each answer about presence/absence of risk factor in patient is estimated in points. After that, depending on obtained sum of points infringements in compliance with therapy are predicted.
EFFECT: invented method makes it possible to realise prediction of infringements in compliance with therapy in patients with schizophrenia for further correction for improvement and positive effect of the therapy itself due to estimation of risk factors.
3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING DEVELOPMENT OF VISCERAL OBESITY IN PATIENTS WITH SCHIZOPHRENIA RECEIVING QUETIAPINE THERAPY | 2017 |
|
RU2659638C1 |
METHOD FOR PREDICTING THE EFFECTIVENESS OF TREATMENT OF PATIENTS WITH SCHIZOPHRENIA | 2021 |
|
RU2775440C1 |
METHOD FOR PREDICTING THE EFFICIENCY OF TREATING PATIENTS WITH SCHIZOPHRENIA WITH ATYPICAL NEUROLEPTIC QUETIAPIN (SEROQUEL) | 2005 |
|
RU2289137C1 |
LABORATORY DIAGNOSTIC TECHNIQUE FOR SCHIZOTYPAL DISORDER | 2014 |
|
RU2569741C1 |
METHOD FOR SUPPORTING MEDICAL DECISIONS ON SELECTION OF ANTIPSYCHOTIC THERAPY IN PATIENTS WITH SCHIZOPHRENIA IN ORDER TO PREVENT AKATHISIA | 2021 |
|
RU2756614C1 |
LABORATORY METHOD OF DIAGNOSING BIPOLAR AFFECTIVE DISORDER | 2013 |
|
RU2558056C2 |
LABORATORY DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR ENDOGENOUS PSYCHOSIS | 2013 |
|
RU2522236C1 |
METHOD FOR PREDICTION OF THE PROBABILITY OF AN UNFAVORABLE OUTCOME IN RELATION TO THE SOCIAL POSTPSYCHOTIC FUNCTIONING OF THE PATIENTS WITH ENDOGENOUS PSYCHIC DISEASES | 2018 |
|
RU2706216C1 |
METHOD FOR PREDICTION OF RISK OF DELAYED DYSKINESIA ACCOMPANYING NEUROLEPTIC THERAPY IN SCHIZOPHRENICS | 2010 |
|
RU2447832C1 |
METHOD FOR PREDICTING THE EFFICIENCY OF TREATING RESIDUAL SCHIZOPHRENIA WITH ATYPICAL NEUROLEPTICS | 2006 |
|
RU2319155C2 |
Authors
Dates
2017-03-01—Published
2016-01-11—Filed